Details
Lamisil Cream is used to treat fungal infections of the skin including the following tinea infections: • Athlete’s foot - between the toes • Jock itch - groin and inner thigh area • Ringworm - commonly affects arms, legs, trunk or neck • Moccasin-type tinea - sole of the foot Lamisil Cream can also be used to treat skin infections caused by Candida, a type of yeast.
Show more
Ingredients
Terbinafine Hydrochloride 10Mg/G,Sorbitan Monostearate,Cetyl Palmitate,Cetyl Alcohol,Stearyl Alcohol,Polysorbate 60,Isopropyl Myristate,Sodium Hydroxide,Purified Water,Benzyl Alcohol.\Nterbinafine Hydrochloride 10Mg/G
View MorePossible interactionsWhile the interactions with other medications are not known, there are interactions with Lamisil Cream.\Nterbinafine Hydrochloride 10Mg/G,
\pamsid\f_b9_drugs. ANY\i_p
ANY\p_b
interactions interactions with other medicinesAlthough not known, interactions with Lamisil Cream have been reported.\Nterbinafine Hydrochloride 10Mg/G,
Lamisil Cream can cause skin reactionsSome side effects have been reported with terbinafine.\Nterbinafine Hydrochloride 10Mg/G,
reported side effectsSome side effects have been reported with terbinafine.\pamsid\f_b9_drugs.
Side effects with terbinafine have been observed to increase as your body gets used to the medicine.\pamsid\f_b9_drugs.
Some side effects have been observed to increase as your body gets used to the medicine.\pamsid\f_b9_drugs.
Lamisil Once (terbinafine)is a generic prescription drug for the treatment of athlete’s foot (tinea pedis). Terbinafine hydrochloride treats athlete’s foot and provides an alternative to topical treatments. Terbinafine hydrochloride has a maximum concentration ofcarbamide (carbohydrate) at the level of the skin and not the other way around. This medicine is available in the strength of one tablet. If you are unable to take a tablet, talk to your pharmacist.
Active Ingredient:Terbinafine HydrochlorideInactive Ingredients:Colloidal Silicon Dioxide, Corn Starch, Sodium Hydroxide, Hydrochloride, Water, etc.
Packaging:10 Tablets in StripDelivery Time:1-2 Days (Usually 10-12 Days)Pack Size:10 TabletsShipment Policy:We Provide Delivery All over the World
How does this medicine work?
Lamisil Once is an anti-fungal medicine that treats athlete's foot (tinea pedis). Terbinafine hydrochloride treats athlete's foot and provides an alternative to topical treatments. If you are unable to take a tablet, you should take a gel capsule instead. You can also use a special tablet for the treatment of athlete's foot and provide an alternative to topical treatments.
VIDEOShow ratings > average ratings
This medicine may be helpful. Not helpful.
View more informationLamisil Once is a topical antifungal medication used to treat athlete's foot (tinea pedis) and ringworm (tinea corporis). It works by killing the fungus that causes athlete's foot and provides relief from itching and burning.
Lamisil Once is available in the following forms:
Lamisil Once may also be used for purposes not listed in this medication guide.In addition to its use for treating athlete's foot and ringworm, Lamisil Once is also used for the treatment of certain infections of the skin and nails.
Lamisil Once is used to treat fungal infections of the skin and nails, such as athlete's foot and ringworm. It can be used for the treatment of athlete's foot and ringworm in athletes who have not had a single infection of the skin or nail caused by fungus.
Lamisil Once should be applied once a day. You should apply it to the affected area where there is irritation or infection and the infection is present for at least 2 hours. Do not use Lamisil Once for a longer period than recommended by your doctor. The treatment can be repeated as needed.
Lamisil Once should be washed thoroughly after applying it to your skin. Clean your hands thoroughly after applying it to your skin. Rinse your eyes and mouth with soap and water. Wash your hands before applying Lamisil Once. You should not use Lamisil Once for more than 2 weeks after you have been prescribed the treatment.
Lamisil Once should be used for weight loss in adolescents and adults. If you gain or lose weight, talk to your doctor about using Lamisil Once for the treatment of your child's weight.
The most common side effects of Lamisil Once are:
Although rare, if you experience a serious allergic reaction, stop using Lamisil Once immediately and contact a doctor or get medical help right away.
100gper pack
Dosage Form:
Inset Dose:Dosage for adults: For treatment of athlete's foot (tinea pedis), the dosage is 100 mg once daily and for treatment of jock itch (tinea cruris), the dosage is 250 mg three times daily. For treatment of ringworm (tinea corporis), the dosage is 250 mg twice daily. The usual starting dose for treatment of tinea corporis is 2 gm orally three times a day for 3-4 days, but this may be decreased if treatment with Lamisil cream is started too early in the course of treatment. For tinea pedis treated with Lamisil cream, a dose of Lamisil cream is applied to the skin twice a day, preferably after a light meal. For the treatment of jock itch, a single application of Lamisil cream may be used, but this may be discontinued if the treatment is stopped after 2 weeks. The course of treatment may vary in duration and length of treatment, and the symptoms may get worse or do not improve after a short course of treatment. It is very important that treatment with Lamisil cream is continued for the recommended duration. If symptoms worsen or are not treated right away, the patient should be advised to consult a physician. For jock itch, the treatment should be started very early, preferably after a light meal. The course should be continued for 3-4 days before the ringworm crusting and developing, and should be continued for 2 days before the tinea cruris rash spreads. The rash should be treated with Lamisil cream once daily for 4 weeks, but should not be continued for longer than that. In addition to the treatment with Lamisil cream, other treatments for tinea pedis, including topical steroids and surgery, are available. Treatment with Lamisil cream may be continued for longer periods of time as long as the patient continues to use the product. When treatment with Lamisil cream has been discontinued, any additional treatments have been discontinued and the patient should be advised to contact a physician if the rash continues or spreads. The patient should be advised to contact the physician if the rash does not improve or if it worsens. The use of Lamisil cream in children is not recommended. As with all medicines, it is important that treatment with Lamisil cream is continued for longer periods of time than prescribed. This may be achieved by continuing the treatment with Lamisil cream, or by stopping the use and consulting with a physician. Lamisil cream should not be used in children under 8 years of age. The safety and efficacy of Lamisil cream in children have not been established, and the responsibility of the manufacturer is not supposed to be transferred to the patient, nor to the physician, nor to the pharmacist, nor to the patient. Lamisil cream should not be used by women or children in their late teens or early twenties, except on doctor's advice. If you notice any abnormal behaviour, depression or thoughts of suicide, or if you think you may be depressed or suicidal, or if you think you may be anxious or nervous, do not give the patient again the dosage or treatment given for any reason, except when advised by a physician. If the rash gets worse or does not improve after 2 weeks of treatment with Lamisil cream, a further 2 weeks of treatment with Lamisil cream may be required. For the treatment of ringworm, a single application of Lamisil cream should be used, but this may be discontinued if the treatment is stopped after 2 weeks. Treatment with Lamisil cream is continued for longer periods of time as long as the patient continues to use the product. When treatment with Lamisil cream has been stopped for longer periods of time, any additional treatments have been discontinued and the patient should be advised to consult a physician. Lamisil cream may be supplied in a single pack, or in a double pack. It is very important that treatment with Lamisil cream is continued for longer periods of time.
A study suggests that the drug might help to prevent a new round of lung cancer.
New findings show the drug is the preferred treatment for the condition that causes the most deaths in the United States, according to a research paper published in the New England Journal of Medicine.
In the study, researchers evaluated the effectiveness of Lamisil, a drug for the treatment of fungal skin infections, in treating people with a group of patients with skin infections.
The study found that the drug had a longer duration of action than the standard treatment of skin infection, with the longer duration of action seen in patients with a shorter duration of action.
The study was published in the journalNew England Journal of Medicineand included nearly 1,000 people who had been treated with Lamisil for fungal skin infections.
The drug was chosen because the drug was approved by the Food and Drug Administration in 2004.
The researchers examined the safety of the drug in patients with fungal skin infections and found that it was not as effective as standard treatment.
“The study showed that the longer-acting treatment did not work,” the study authors wrote in a press release.
The Journal of the American Academy of Dermatology. It was also the first study of Lamisil for the treatment of fungal skin infections.
The Lancetand was funded by the Bristol-Myers Squibb Pharmaceutical Company.
|The study was presented at the American Society of Clinical Oncology’s annual meeting, which took place in Chicago on Jan. 20.
It found that the drug did not lead to a significant increase in the risk of recurrence, as well as a reduction in the risk of cancer recurrence, compared with the standard treatment of skin infection.
The findings were published in thein April.
“Our findings support the current findings of a new study in which a small, long-acting treatment of fungal skin infections did not appear to be associated with an increase in the risk of recurrence,” the researchers said in the press release.
The study was published in the, an international journal of oncology.
The study is part of the “New England Journal of Medicinejournal of clinical oncology.
“There is a need for further studies in the field of oncology to explore the possibility of using this treatment to prevent cancer recurrence,” the authors said.
“Our findings show that Lamisil is a suitable treatment for the treatment of fungal skin infections in patients with a known infection and that there is no evidence that it is superior to standard treatment of other types of skin infection, such as other infections.”
The study was published inand was supported by the Bristol-Myers Squibb Pharmaceutical Company.
The researchers said that the drug had a longer duration of action than the standard treatment of skin infection, with the longer duration of action seen in patients with a shorter duration of action.
“This is the first time that it has been used as a treatment for skin infections in a clinical setting, and that it has been shown to be as effective as standard therapy,” the authors wrote in the press release.
The researchers said they are hopeful that the results of the study will encourage further studies in the field of oncology.
The drug is known for its long duration of action.
It has been used in people with fungal skin infections for many years, the study authors said.
“We’ve been able to determine that the longer-acting treatment of fungal skin infections has not been associated with a significant increase in the risk of recurrence or cancer recurrence compared with the standard treatment,” the researchers said.
The researchers said they believe that the results of the study may help to support the development of new types of drugs that can be used in the treatment of fungal skin infections.
Stade de France Pharmacy